SCHEMBL9485723

SCHEMBL9485723

COC(C)n1cnc(CN2CCc3c(c4cccc(F)c4n3C)C2=O)c1C

nearest known ligand 0.44

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.44
HTR2C P28335 2/20 0.44
HTR2B P41595 2/20 0.44
KCNH2 Q12809 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADRA2C P18825 1/20 0.44
ADRA1A P35348 1/20 0.44
HTR3A P46098 1/20 0.44
CASP6 P55212 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7295411 0.85 HTR2A (0.49) HTR2AHTR2CHTR2BKCNH2CYP1A2
SCHEMBL7285963 0.84 KCNH2 (0.45) HTR2AHTR2CHTR2BKCNH2CYP1A2
SCHEMBL9485728 0.83 KCNH2 (0.44) HTR2AHTR2CHTR2BKCNH2CYP1A2
SCHEMBL9485681 0.79 KCNH2 (0.44) HTR2AHTR2CHTR2BKCNH2CYP1A2
Lurosetron SCHEMBL30949356 0.77 KCNH2 (0.72) HTR2AHTR2CHTR2BKCNH2CYP1A2
Lurosetron SCHEMBL788289 0.77 KCNH2 (0.72) HTR2AHTR2CHTR2BKCNH2CYP1A2
SCHEMBL7284034 0.77 KCNH2 (0.42) HTR2AHTR2CHTR2BKCNH2CYP1A2
Lurosetron SCHEMBL7336906 0.77 KCNH2 (0.71) HTR2AHTR2CHTR2BKCNH2CYP1A2
Lurosetron SCHEMBL7291773 0.77 CASP6 (0.72) HTR2AHTR2CHTR2BKCNH2CYP1A2
SCHEMBL7286207 0.76 KCNH2 (0.41) HTR2AHTR2CHTR2BKCNH2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed